Yan Xijun: improve the evaluation of high quality and high price of traditional Chinese medicine and establish the mechanism of survival of the fittest

Source: Yan Xijun, chairman of wisdom ashdak news agency, submitted a proposal on improving the evaluation mechanism of high quality and good price of traditional Chinese medicine during the two sessions on March 3, 2014, suggesting that the evaluation work of high quality and good price should be carried out as soon as possible, the evaluation standard system should be continuously established and improved, and the dynamic supervision management and survival mechanism should be established Yan Xijun said that the national development and Reform Commission began to entrust China Association of traditional Chinese medicine with the review of high quality and high price in 2001 However, with the development of pharmaceutical technology, the improvement of Pharmacopoeia standards, and the implementation of new GMP, the review has not been able to effectively achieve the purpose of improving product quality by giving high price, It has become an important means for some products with high quality and good price to maintain their monopoly position, obtain high profits and attack competitors The evaluation mechanism of high quality and good price needs to be improved Yan Xijun suggested that the quality and good price evaluation work should continuously establish and improve the evaluation standard system, combining with the current actual situation; establish the dynamic supervision and management of the quality and good price evaluation of traditional Chinese medicine and the survival of the fittest mechanism He said that the quality of drugs is a dynamic management process, and a dynamic monitoring and evaluation mechanism should also be established, while promoting the continuous improvement of the quality of traditional Chinese medicine through the introduction of elimination mechanism It is understood that high quality and good price is an important evaluation index in the current provincial bidding and national drug pricing work Before Jilin Province in the formulation of base drug bidding policy, it was clearly stipulated that high quality and good price varieties were given higher weight in the quality level